Diagnostic Imaging Services Market Analysis by Application, Modality, End User, and Region - Global Forecast to 2029 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Nov 30, 2022--

The "Diagnostic Imaging Services Market Analysis by Application, by Modality, By End User, and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

Rising public awareness of early disease detection and the expanded reach of clinical applications, growing rapidly aging populations, and associated disease prevalence are some of the key drivers of the market.

However, outpatient imaging facilities that have a low reimbursement structure and expensive diagnostic imaging systems are expected to restrain the market growth.

Regional Markets

In 2021, North America had the greatest share of the market due to geriatric syndromes are becoming more prevalent in this area, suggesting an increase in demand for medical imaging diagnostics services, and modern technology supplied by top diagnostic imaging service providers, which is driving the worldwide diagnostic imaging services market.

The Asia Pacific market, on the other hand, is expected to develop at the fastest CAGR during the forecast period, owing to improved healthcare infrastructure, increased diagnostic imaging investments, better reimbursement scenarios, and expanding insurance coverage in various APAC nations.

Competitor Insights

• Novant Health (US)
• Alliance Medical (UK)
• Medica Group (UK)
• Sonic Healthcare (Australia)
• Global Diagnostics (Australia)
• Healthcare Imaging Services Pty Ltd. (Australia)
• RadNet Inc (US)
• Center for Diagnostic Imaging Inc. (CDI) (US)
• InHealth Group (UK)
• Concord Medical Services Holdings Limited (China)
• Dignity Health (US)

Segmentation: Diagnostic Imaging Services Market Analysis Report 2021-2029

Application (Revenue, USD Million)

• Nuclear Imaging
• Oncology
• Neurology
• Cardiovascular
• Mammography
• Other Nuclear Imaging Applications
• X-ray Imaging
• Dentistry
• Fluoroscopy
• General Radiography
• Computed Tomography
• Neurology
• Oncology
• Cardiovascular
• Other CT Applications
• Magnetic Resonance Imaging
• Orthopedics
• Cardiovascular
• Ultrasound
• Oncology
• Obstetrics & Gynecology
• Neurology
• Pelvic & Abdomen
• Orthopedics
• Other Ultrasound Applications

Modality (Revenue, USD Million)

• Ultrasound
• Nuclear Imaging
• X-ray Imaging
• Computed Tomography (CT)
• Mammography
• Magnetic Resonance Imaging (MRI)

End User (Revenue, USD Million)

• Ambulatory Care Centers
• Hospitals
• Diagnostic Centers
• Research and Academia

By Region (Revenue, USD Million)

North America

• U.S
• Canada

Europe

• Germany
• France
• UK
• Spain
• Italy
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Rest of APAC

Latin America

• Brazil
• Mexico
• Argentina
• Rest of LATAM

Middle East & Africa

• South Africa
• GCC
• Rest of MEA

For more information about this report visit https://www.researchandmarkets.com/r/z67szv

View source version on businesswire.com:https://www.businesswire.com/news/home/20221130005641/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2022.